Evidence map›Paper›PMID 26203270›Full record

ArticleClinical and experimental gastroenterology2015

Risk factors for recurrent hospital-acquired Clostridium difficile infection in a Japanese university hospital.

Mayu Hikone, Yusuke Ainoda, Sayaka Tago, Takahiro Fujita, Yuji Hirai, Kaori Takeuchi, Kyoichi Totsuka

Open access · goldAbstract read
In one paragraph

Article in Clinical and experimental gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Global burden ofJournal of global health · 2019
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Implementation of multifaceted diagnostic stewardship forAntimicrobial stewardship & healthcare epidemiology : ASHE · 2024
    Article
  7. Article
  8. Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mayu HikoneDepartment of Infectious Diseases, Tokyo Metropolitan Bokutoh General Hospital, Tokyo Women's Medical University, Tokyo, Japan.
Yusuke AinodaDepartment of Infectious Diseases, Tokyo Metropolitan Bokutoh General Hospital, Tokyo Women's Medical University, Tokyo, Japan ; Department of Infectious Diseases, Tokyo Women's Medical University, Tokyo, Japan.
Sayaka TagoDepartment of Infectious Diseases, Tokyo Women's Medical University, Tokyo, Japan.
Takahiro FujitaDepartment of Infectious Diseases, Tokyo Women's Medical University, Tokyo, Japan.
Yuji HiraiDepartment of Infectious Diseases, Tokyo Women's Medical University, Tokyo, Japan.
Kaori TakeuchiDepartment of Infectious Diseases, Tokyo Women's Medical University, Tokyo, Japan.
Kyoichi TotsukaDepartment of Internal Medicine, Kitatama Hospital, Tokyo, Japan.
Tokyo Women's Medical University · JPKuma Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClostridium difficile infection (CDI) is a highly prevalent hospital-associated infection. Although most patients respond well to discontinuation of antibiotics, 20%-30% of patients relapse. To initiate early therapeutic measures, the risk factors for recurrent CDI must be identified, although very few Japanese studies have used standard surveillance definitions to identify these risk factors.

methodsWe retrospectively reviewed the medical records of patients with health care facility-onset CDI between August 2011 and September 2013. Patients with diarrhea who were positive for Clostridium difficile (via an enzyme immunoassay) were defined as having CDI. Clinical data (eg, demographics, comorbidities, medication, laboratory results, and clinical outcomes) were evaluated, and multivariate analysis was used to identify risk factors that were associated with recurrent CDI.

resultsSeventy-six health care facility-onset CDI cases were identified, with an incidence rate of 0.8 cases per 10,000 patient-days. Fourteen cases (18.4%) were recurrent, with 13 patients having experienced a single recurrent episode and one patient having experienced three recurrent episodes. The 30-day and 90-day mortality rates were 7.9% and 14.5%, respectively. Multivariate analysis revealed that recurrent patients were more likely to have underlying malignant disease (odds ratio: 7.98; 95% confidence interval: 1.22-52.2; P=0.03) and a history of intensive care unit hospitalization (odds ratio: 49.9; 95% confidence interval: 1.01-2,470; P=0.049).

conclusionIntensive care unit hospitalization and malignancy are risk factors for recurrent CDI. Patients with these factors should be carefully monitored for recurrence and provided with appropriate antimicrobial stewardship.

Indexed as

Clostridium difficilerecurrent infectionrisk factors

Identifiers

PMID26203270
PMCPMC4507450
OpenAlexW1582179177

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.